Find Research Outputs

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Gerald Watts
2019

FAMILIAL HYPERCHOLESTEROLAEMIA - TIME FOR A GREATER ROLE FOR PRIMARY CARE

Brett, T., Arnold-Reed, D., Ping-Delfos, W. C. S., Condon, C. & Watts, G. F., Aug 2019, In : Atherosclerosis. 287, p. E209-E209 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2016

Diabetes, statins and FH

Fuentes, F., Alcalá-Díaz, J. F., Watts, G. F. & Mata, P., 2016, In : International Journal of Cardiology. 203, p. 575 575 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)
2017

Comprehending the Health informatics Spectrum: Grappling with System Entropy and Advancing Quality Clinical Research

Bellgard, M. I., Chartres, N., Watts, G. F., Wilton, S., Fletcher, S., Hunter, A. & Snelling, T., 14 Sep 2017, In : Frontiers in Public Health. 5, 5 p., 224.

Research output: Contribution to journalEditorial

Open Access

Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a)

Vuorio, A., Watts, G. F. & Kovanen, P. T., 2017, In : European Heart Journal. 38, 48, p. 3555-3559 7 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)
2016
1 Citation (Scopus)

ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity

Verges, B., Adiels, M., Borén, J., Barrett, H., Watts, G., Chan, D., Duvillard, L., Soderlund, S., Matikainen, N., Kahri, J., Lundbom, N., Lundbom, J., Hakkarainen, N., Aho, S., Simoneau-Robin, I. & Taskinen, M. R., 1 Apr 2016, In : Journal of Clinical Endocrinology and Metabolism. 101, 4, p. 1398-1406 9 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
2019

Status of PCSK9 Monoclonal Antibodies in Australia

Scherer, D. J., Nelson, A. J., O'Brien, R., Kostner, K. M., Hare, D. L., Colquhoun, D. M., Barter, P. J., Aylward, P., Nicholls, S. J. & Watts, G. F., 1 Oct 2019, In : Heart Lung and Circulation. 28, 10, p. 1571-1579 9 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies

Pirro, M., Simental-Mendia, L. E., Bianconi, V., Watts, G. F., Banach, M. & Sahebkar, A., Jan 2019, In : Journal of Clinical Medicine. 8, 1, 14 p., 118.

Research output: Contribution to journalReview article

Open Access

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia

Ellis, K. L., Pérez de Isla, L., Alonso, R., Fuentes, F., Watts, G. F. & Mata, P., 12 Mar 2019, In : Journal of the American College of Cardiology. 73, 9, p. 1029-1039 11 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)
2019

Identifying Perceptions and Preferences of the General Public Concerning Universal Screening of Children for Familial Hypercholesterolaemia

Bowman, F. L., Molster, C. M., Lister, K. J., Bauskis, A. T., Garton-Smith, J., Vickery, A. W., Watts, G. F. & Martin, A. C., 22 Jul 2019, In : Public Health Genomics.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)
2018

Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials

Sahebkar, A., Simental-Mendía, L. E., Pirro, M., Banach, M., Watts, G. F., Sirotri, C., Al-Rasadi, K. & Atkin, S. L., 1 Dec 2018, In : Scientific Reports. 8, 1, 17887.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)
2019

Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy

Warden, B. A., Minnier, J., Watts, G. F., Fazio, S. & Shapiro, M. D., 26 Apr 2019, In : Journal of Clinical Lipidology.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Homozygous familial hypercholesterolaemia in childhood – The first case report in Southeast Europe

Bjelakovic, B., Stefanutti, C., Pisciotta, L., Watts, G. & Bejiqi, R., Dec 2019, In : Atherosclerosis Supplements. 40, p. 122-124 3 p.

Research output: Contribution to journalArticle

Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH

Santos, R. D. & Watts, G. F., Feb 2019, In : Atherosclerosis. 281, p. 145-147 3 p.

Research output: Contribution to journalEditorial

2018

Editorial introductions (in Current Opinion in Lipidology)

Stroes, E. S. G. & Watts, G. F., Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 433-433 1 p.

Research output: Contribution to journalEditorial

2017
Open Access
2018

Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?

Ellis, K. L. & Watts, G. F., 1 May 2018, In : Cardiology Clinics. 36, 2, p. 287-298 12 p.

Research output: Contribution to journalReview article

3 Citations (Scopus)
2017

Insulin resistance and vascular dysfunction in chronic kidney disease: Mechanisms and therapeutic interventions

Chan, D. T., Watts, G. F., Irish, A. B. & Dogra, G. K., Aug 2017, In : Nephrology, Dialysis, Transplantation. 32, 8, p. 1274–1281 8 p.

Research output: Contribution to journalLiterature review

Open Access
7 Citations (Scopus)
2019
2018

Lipoprotein(a): lodestar for future clinical trials

Watts, G. F. & Boffa, M. B., 13 Oct 2018, In : The Lancet. 392, 10155, p. 1281-1282 2 p.

Research output: Contribution to journalComment/debate

5 Citations (Scopus)
2019
2 Citations (Scopus)
2017

The renaissance of lipoprotein(a): Brave new world for preventive cardiology?

Ellis, K. L., Boffa, M. B., Sahebkar, A., Koschinsky, M. L. & Watts, G. F., 1 Oct 2017, In : Progress in Lipid Research. 68, p. 57-82 26 p.

Research output: Contribution to journalReview article

27 Citations (Scopus)
2018

The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on anticoagulation therapy in rural Australia

Bellinge, J. W., Paul, J. J., Walsh, L. S., Garg, L., Watts, G. F. & Schultz, C., 15 Jan 2018, In : The Medical journal of Australia. 208, 1, p. 18-23 6 p.

Research output: Contribution to journalArticle

Open Access
5 Citations (Scopus)
2019

Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it

Lan, N. S. R., Fegan, P. G., Yeap, B. B., Rankin, J. M. & Watts, G. F., 1 Jul 2019, In : Diabetes, Obesity and Metabolism. 21, 7, p. 1734-1736 3 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2018
15 Citations (Scopus)
2019

Dyslipidaemia in adults with type 1 diabetes-when to treat?

Lan, N. S. R., Fegan, P. G., Yeap, B. B., Bell, D. A. & Watts, G. F., Jan 2019, In : Diabetes/Metabolism Research and Reviews. 35, 1, 5 p., 3090.

Research output: Contribution to journalEditorial

2 Citations (Scopus)
2016

PCSK9 inhibitors - mechanisms of action

Page, M. M. & Watts, G. F., Oct 2016, In : Australian Prescriber. 39, 5, p. 164-167 4 p.

Research output: Contribution to journalArticle

Open Access
22 Citations (Scopus)
2019

Implementing simple algorithms to improve glucose and lipid management in people with diabetes and acute coronary syndrome

Lan, N. S. R., Fegan, P. G., Rankin, J. M., Bell, D. A., Watts, G. F. & Yeap, B. B., Dec 2019, In : Diabetic Medicine. 36, 12, p. 1643-1651 9 p.

Research output: Contribution to journalArticle

PCSK9 inhibition 2018: riding a new wave of coronary prevention

Ward, N. C., Page, M. M. & Watts, G. F., 31 Jan 2019, In : Clinical Science. 133, 2, p. 205-224 20 p.

Research output: Contribution to journalReview article

7 Citations (Scopus)

PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies

Ruscica, M., Watts, G. F. & Sirtori, C. R., Jun 2019, In : European Journal of Preventive Cardiology. 26, 9, p. 998-1000 3 p.

Research output: Contribution to journalEditorial

6 Citations (Scopus)
2018

Improving the global care of familial hypercholesterolaemia: Starting the ball rolling

Ray, K. K. & Watts, G. F., 1 Oct 2018, In : Atherosclerosis. 277, p. 230-233 4 p.

Research output: Contribution to journalEditorial

4 Citations (Scopus)
2016

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

Vallejo-Vaz, A. J., Akram, A., Kondapally Seshasai, S. R., Cole, D., Watts, G., Hovingh, G. K., Kastelein, J. J. P., Mata, P., Raal, F. J., Santos, R. D., Soran, H., Freiberger, T., Abifadel, M., Aguilar-Salinas, C. A., Alnouri, F., Alonso, R., Al-Rasadi, K., Banach, M., Bogsrud, M. P., Bourbon, M. & 52 others, Bruckert, E., Car, J., Ceska, R., Corral, P., Descamps, O., Dieplinger, H., Do, C. T., Durst, R., Ezhov, M. V., Fras, Z., Gaita, D., Gaspar, I. M., Genest, J., Harada-Shiba, M., Jiang, L., Kayikcioglu, M., Lam, C. S. P., Latkovskis, G., Laufs, U., Liberopoulos, E., Lin, J., Lin, N., Maher, V., Majano, N., Marais, A. D., März, W., Mirrakhimov, E., Miserez, A. R., Mitchenko, O., Nawawi, H., Nilsson, L., Nordestgaard, B. G., Paragh, G., Petrulioniene, Z., Pojskic, B., Reiner, Ž., Sahebkar, A., Santos, L. E., Schunkert, H., Shehab, A., Slimane, M. N., Stoll, M., Su, T. C., Susekov, A., Tilney, M., Tomlinson, B., Tselepis, A. D., Vohnout, B., Widén, E., Yamashita, S., Catapano, A. L. & Ray, K. K., 2016, In : Atherosclerosis Supplements. 22, p. 1-32

Research output: Contribution to journalArticle

Open Access
55 Citations (Scopus)
2017

The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis

Hahn, L. A., Mackinnon, A., Foley, D., Morgan, V. A., Waterreus, A., Watts, G. F., Castle, D. J., Liu, D. & Galletly, C. A. A., Apr 2017, In : Schizophrenia Research. 182, p. 13-18 6 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis

Hahn, L. A. A., MacKinnon, A., Foley, D. L. L., Morgan, V. A., Waterreus, A., Watts, G. F., Castle, D. J., Liu, D. & Galletly, C. A. A., Jun 2017, In : Schizophrenia Research. 184, p. 88-95 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2016

Risk factors for obstructive sleep apnea are prevalent in people with psychosis and correlate with impaired social functioning and poor physical health

Liu, D., Myles, H., Foley, D. L., Watts, G. F., Morgan, V. A., Castle, D., Waterreus, A., Mackinnon, A. & Galletly, C. A., 2016, In : Frontiers in Psychiatry. 7, AUG, p. 139

Research output: Contribution to journalArticle

Open Access
5 Citations (Scopus)

Common familial risk factors for schizophrenia and diabetes mellitus

Foley, D. L., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A. & Galletly, C. A., 2016, In : Australian & New Zealand Journal of Psychiatry. 50, 5, p. 488–494

Research output: Contribution to journalArticle

16 Citations (Scopus)
2019

Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia

Pérez de Isla, L., Ray, K. K., Watts, G. F., Santos, R. D., Alonso, R., Muñiz-Grijalvo, O., Diaz-Diaz, J. L., Badimon, L., Catapano, A. L. & Mata, P., 1 Jul 2019, In : Atherosclerosis. 286, p. 40-45 6 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2017

World Heart Federation Cholesterol Roadmap

Murphy, A., Faria-Neto, J. R., Al-Rasadi, K., Blom, D., Catapano, A., Cuevas, A., Lopez-Jimenez, F., Perel, P., Santos, R., Sniderman, A., Sy, R., Watts, G. F., Zhao, D., Yusuf, S. & Wood, D., 1 Sep 2017, In : Global Heart. 12, 3, p. 179-197.e5

Research output: Contribution to journalArticle

8 Citations (Scopus)

Isolated Elevation of Lipoprotein(A) is Uncommon Among Patients Admitted to Coronary Care

Ellis, K. L., Pang, J., Bell, D. A., Burnett, J. R., Schultz, C., Hillis, G. S. & Watts, G. F., 2017, In : Heart, Lung and Circulation. 26, Supp. 2, p. S84 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2018
6 Citations (Scopus)
2016

Fasting is not routinely required for determination of a lipid profile: Clinical and Laboratory implications including flagging at desirable concentration cutpoints-A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

Nordestgaard, B. G., Langsted, A., Mora, S., Kolovou, G., Baum, H., Bruckert, E., Watts, G., Sypniewska, G., Wiklund, O., Borén, J., Chapman, M. J., Cobbaert, C., Descamps, O. S., Von Eckardstein, A., Kamstrup, P. R., Pulkki, K., Kronenberg, F., Remaley, A. T., Rifai, N., Ros, E. & 1 others, Langlois, M., 2016, In : Clinical Chemistry. 62, 7, p. 930-946

Research output: Contribution to journalArticle

Open Access
81 Citations (Scopus)
2017

Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of head-to-head randomized controlled trials

Sahebkar, A., Simental-Mendía, L. E., Watts, G. F., Serban, M. C., Banach, M. & Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, 3 Feb 2017, In : BMC Medicine. 15, 1, 22.

Research output: Contribution to journalArticle

Open Access
28 Citations (Scopus)
2016

N-3 fatty acid supplementation and leukocyte telomere length in patients with chronic kidney disease

Barden, A., O’callaghan, N., Burke, V., Mas, E., Beilin, L., Fenech, M., Irish, A. B., Watts, G., Puddey, I., Huang, R-C. & Mori, T., 19 Mar 2016, In : Nutrients. 8, 3, p. 1-11 11 p., 175.

Research output: Contribution to journalArticle

Open Access
17 Citations (Scopus)
2019

The effects of omega-3 fatty acid supplementation upon interleukin-12 and interleukin-18 in chronic kidney disease patients

Yong, K., Mori, T., Chew, G., Beilin, L. J., Puddey, I., Watts, G. F., Irish, A., Dogra, G., Boudville, N. & Lim, W., Sep 2019, In : Journal of Renal Nutrition. 29, 5, p. 377-385 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2020

A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome

Kiaie, N., Gorabi, A. M., Penson, P. E., Watts, G., Johnston, T. P., Banach, M. & Sahebkar, A., Jan 2020, In : Drug Discovery Today. 25, 1, p. 58-72 15 p.

Research output: Contribution to journalReview article

2 Citations (Scopus)
2016

The impact of statin therapy on plasma levels of von Willebrand factor antigen: Systematic review and meta-analysis of Randomised placebo-controlled trials

Sahebkar, A., Serban, C., Ursoniu, S., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Bittner, V., Ray, K. K., Watts, G. F., Kees Hovingh, G., Rysz, J., Kastelein, J. J. P. & Banach, M., 2016, In : Thrombosis and Haemostasis. 115, 3, p. 520-532 13 p.

Research output: Contribution to journalReview article

61 Citations (Scopus)

Statin therapy and plasma free fatty acids: A systematic review and meta-analysis of controlled clinical trials

Sahebkar, A., Simental-Mendía, L. E., Pedone, C., Ferretti, G., Nachtigal, P., Bo, S., Derosa, G., Maffioli, P. & Watts, G. F., 2016, In : British Journal of Clinical Pharmacology. 81, 5, p. 807-818 12 p.

Research output: Contribution to journalReview article

17 Citations (Scopus)